Sanne Kreijkamp-Kaspers

Sanne Kreijkamp-Kaspers

Auto-generated profile, based on publicly available information

Sanne Kreijkamp-Kaspers

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2004 in JAMA
Verified
Journal Article
Open access
PDF file
SKSanne Kreijkamp-Kaspers
Sanne Kreijkamp-Kaspers
LKLinda Kok
Linda Kok
DGDiederick E. Grobbee
Diederick E. Grobbee
EHE.H.F. (Edward) De Haan
E.H.F. (Edward) De Haan
AAAndré Aleman
André Aleman
YSYvonne T. van der Schouw
Yvonne T. van der Schouw
The sudden decline in estrogen levels after menopause coincides with acceleration of several aging processes.1 On average, bone mineral density (BMD) decreases and cognitive function declines, whereas total cholesterol and low-density lipoprotein cholesterol (LDL-C) increase. It has been suggested that postmenopausal estrogen therapy might counteract some of these changes. However, short-term estrogen use is associated with the recurrence of vaginal bleeding,2 and long-term use has been associated with an increased risk of breast cancer,3,4 stroke,5 and cardiovascular disease.4

1 February 2005 in Circulation
Verified
Journal Article
Closed access
YSYvonne T. van der Schouw
Yvonne T. van der Schouw
SKSanne Kreijkamp-Kaspers
Sanne Kreijkamp-Kaspers
PPPetra H.M. Peeters
Petra H.M. Peeters
LKLital Keinan-Boker
Lital Keinan-Boker
EREric B. Rimm
Eric B. Rimm
DGDiederick E. Grobbee
Diederick E. Grobbee
Background— Phytoestrogens have been suggested to lower cardiovascular disease risk, but existing research focused on non-Western high intake levels and on risk factors. We investigated whether habitual low phytoestrogen intake is associated with manifest cardiovascular disease risk. Methods and Results— Between 1993 and 1997, 16 165 women 49 to 70 years old and free from cardiovascular disease were enrolled in the Dutch Prospect-EPIC cohort (European Prospective study Into Cancer and nutrition) and followed up for a median period of 75 months. At enrollment, women filled in questionnaires on chronic disease risk factors and nutrition. Intake of phytoestrogens was estimated using the food frequency questionnaire covering regular dietary intake of 178 food items in the year before enrollment. Cox regression analysis was used to estimate hazard ratios of cardiovascular disease for quartiles of phytoestrogen intake adjusted for age at intake, body mass index, smoking, physical activity, hypertension, hypercholesterolemia, use of hormone replacement therapy, menopausal status, and intake of total energy, total fiber, vegetables, fruit, and alcohol. In total, 372 women experienced a coronary event (CHD) (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9], 410 to 414, 427.5) and 147 women a cerebrovascular event (CVD) (ICD-9, 430 to 438) during follow-up. Overall, neither isoflavones nor lignans were associated with decreased cardiovascular disease risk. When stratifying for ever versus never smokers, CHD risk decreased with increasing lignan intake for ever smokers. Conclusions— Our results do not support the presence of a protective effect of higher intake of phytoestrogens in low doses on cardiovascular disease risk, although a small risk reduction with higher lignan intake cannot be excluded for smokers.

1 January 2005 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
SKSanne Kreijkamp-Kaspers
Sanne Kreijkamp-Kaspers
LKLinda Kok
Linda Kok
MBMichiel L Bots
Michiel L Bots
DGDiederick E Grobbee
Diederick E Grobbee
JLJohanna W Lampe
Johanna W Lampe
YSYvonne T van der Schouw
Yvonne T van der Schouw
Background: The incidence of cardiovascular disease increases after menopause, possibly because of the decline in estrogen. Soy protein, a rich source of estrogen-like isoflavones, is hypothesized to improve vascular function. Objective: The objective of this study was to investigate whether supplementation with soy protein, a rich source of estrogen-like isoflavones, improves vascular function. Design: We performed a 12-mo double-blind randomized trial to compare the effects of soy protein containing 99 mg isoflavones/d (aglycone weights) with those of milk protein (placebo) on blood pressure and endothelial function in 202 postmenopausal women aged 60–75 y. Results: Changes in endothelial function during the intervention were not significantly different between the soy and the placebo groups. After the intervention, systolic blood pressure increased in the soy group significantly more than it did in the placebo group; the difference in change was 4.3 mm Hg (95% CI: 0.3, 8.4 mm Hg;P = 0.04) for systolic blood pressure, but only 2.0 mm Hg (95% CI: −0.74, 4.71 mm Hg;P = 0.15) for diastolic blood pressure. In the soy group only, systolic and diastolic blood pressure decreased and endothelial function improved in the equol producers, whereas systolic and diastolic blood pressure increased and endothelial function deteriorated in the equol nonproducers. Conclusions: The results of this trial do not support the hypothesis that soy protein containing isoflavones have beneficial effects on vascular function in older postmenopausal women. Whether certain subgroups of women (eg, equol producers) do benefit from the intervention remains to be elucidated.

16 April 2013 in Autoimmunity Highlights
Verified
Journal Article
Open access
PDF file
EBE. W. Brenu
E. W. Brenu
SHS. L. Hardcastle
S. L. Hardcastle
GAG. M. Atkinson
G. M. Atkinson
MDM. L. van Driel
M. L. van Driel
SKS. Kreijkamp-Kaspers
S. Kreijkamp-Kaspers
SMS. M. Marshall-Gradisnik
S. M. Marshall-Gradisnik
Maintenance of health and physiological homeostasis is a synergistic process involving tight regulation of proteins, transcription factors and other molecular processes. The immune system consists of innate and adaptive immune cells that are required to sustain immunity. The presence of pathogens and tumour cells activates innate immune cells, in particular Natural Killer (NK) cells. Stochastic expression of NK receptors activates either inhibitory or activating signals and results in cytokine production and activation of pathways that result in apoptosis of target cells. Thus, NK cells are a necessary component of the immunological process and aberrations in their functional processes, including equivocal levels of NK cells and cytotoxic activity pre-empts recurrent viral infections, autoimmune diseases and altered inflammatory responses. NK cells are implicated in a number of diseases including chronic fatigue syndrome (CFS). The purpose of this review is to highlight the different profiles of NK cells reported in CFS patients and to determine the extent of NK immune dysfunction in subtypes of CFS patients based on severity in symptoms.

1 May 2007 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
SKSanne Kreijkamp-Kaspers
Sanne Kreijkamp-Kaspers
LKLinda Kok
Linda Kok
DGDiederick E. Grobbee
Diederick E. Grobbee
EHE.H.F. (Edward) De Haan
E.H.F. (Edward) De Haan
AAAndré Aleman
André Aleman
YSYvonne T. van der Schouw
Yvonne T. van der Schouw
Background. Aging is associated with a decline in cognitive function; we explored the possible influence of dietary phytoestrogens on this decline. Methods. We conducted a cross-sectional study in 301 Dutch women aged 60–75 years. Dietary isoflavone and lignan intake was assessed with a food-frequency questionnaire covering habitual diet in the year preceding enrolment. The endpoints were cognitive function measured in three domains: memory, processing capacity and speed, and executive function. Data were analyzed using linear regression models, after adjusting for confounders. Results. No association between dietary isoflavone intake and cognitive function was found. High lignan intake was associated with a better performance in processing capacity and speed, and in executive function (p for trend over quartiles =.01 and.02, respectively). Conclusions. This finding calls for further research to elucidate the relatively underexplored role of lignans within the range of phytoestrogens.

1 October 2008 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
MVMartijn Verheus
Martijn Verheus
CGCarla H. van Gils
Carla H. van Gils
SKSanne Kreijkamp-Kaspers
Sanne Kreijkamp-Kaspers
LKLinda Kok
Linda Kok
PPPetra H.M. Peeters
Petra H.M. Peeters
YSYvonne T. van der Schouw
Yvonne T. van der Schouw
Background: The relatively high dietary intake of soy in Asian countries has been hypothesized to, at least partly, explain the lower breast cancer incidence patterns in these countries compared with the Western world. The aim of the present study was to determine the effect of daily soy supplementation on mammographic density, one of the strongest known risk factors for breast cancer.Methods: A double-blind, randomized, controlled trial was conducted to compare the effects of soy protein intake containing 99 mg isoflavones daily with intake of milk protein (placebo) for the duration of 1 year. Two hundred and two Dutch postmenopausal women ages 60 to 75 years were randomized. Mammographic density was assessed using a quantitative computer-assisted method on digitized mammograms. Equol producer status was assessed in plasma provided at the final visit (soy group) or after a 3-day challenge with soy after the trial was finished (placebo group).Results: A total of 175 women completed the baseline visits and at least one follow-up visit and were included in the intention-to-treat analyses. For 126 women, both pre- and post-trial mammograms were available. Mammographic density decreased in both study arms, but the decrease did not differ significantly between intervention and placebo groups. Equol producer status did not modify the results.Conclusion: The results of this trial do not support the hypothesis that a diet high in soy protein among postmenopausal women decreases mammographic density. (Cancer Epidemiol Biomarkers Prev 2008;17(10):2632–8)